SCHEMBL5773383

SCHEMBL5773383

Cc1nc(O)c2nc(-c3ccc(Cl)cc3)cc-2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCL12 P48061 2/20 0.41
KMT2A Q03164 6/20 0.40
MEN1 O00255 5/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
MCL1 Q07820 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 2/20 0.37
ADORA3 P0DMS8 1/20 0.37
CTRC Q99895 1/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770748 0.88 MEN1 (0.43) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL5775574 0.86 KMO (0.44) CXCL12KMT2AMEN1NPC1RAB9A
SCHEMBL5774514 0.85 MEN1 (0.44) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL5774357 0.85 ADORA3 (0.48) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL5772706 0.85 MEN1 (0.40) CXCL12KMT2AMEN1NPC1RAB9A
SCHEMBL5774961 0.85 MGAM (0.43) ADORA3
SCHEMBL5773819 0.83 KDM4E (0.48) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL5772874 0.80 KDM4E (0.47) KMT2AMEN1RAB9AMAPTLMNA
SCHEMBL5773724 0.79 ADORA3 (0.44) MAPTMAPK1ADORA3
SCHEMBL5775897 0.76 MEN1 (0.45) KMT2AMEN1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed